The treatment of hepatolenticular degeneration.
D003545:Cysteine / Q000031:analogs & derivatives; D004112:Dimercaprol / Q000627:therapeutic use*; D006527:Hepatolenticular Degeneration; D006801:Humans
D004112:Dimercaprol; D003545:Cysteine
CYSTEINE/related compounds; DIMERCAPROL/therapeutic use; HEPATOLENTICULAR DEGENERATION
N Engl J Med. 1957 Feb 7;256(6):235-42
13400241
N Engl J Med. 1951 Dec 13;245(24):917-25
14882450
Neurology. 1953 Aug;3(8):569-76
13087576
Q J Med. 1952 Oct;21(84):425-46
13004260
Rev Neurol (Paris). 1955 Nov;93(5):701-29
13323792
Q J Med. 1957 Oct;26(104):527-58
13494696
Nature. 1958 Jan 11;181(4602):115-6
13493612
Arch Biochem. 1950 Oct;28(3):452-63
14790786
Science. 1957 Nov 15;126(3281):1014-5
13486052
J Clin Pathol. 1949 Aug;2(3):193-6
16810852
Am J Med. 1953 Oct;15(4):442-9
13092113
Science. 1952 Oct 31;116(3018):484-5
12994898
Am J Med Sci. 1956 May;231(5):511-8
13313537
Klin Wochenschr. 1956 Sep 15;34(35-36):961-8
13377617
Trans Assoc Am Physicians. 1954;67:232-41
13216832
J Clin Invest. 1950 Mar;29(3):265-78
16695797
Lancet. 1956 Jan 7;270(6906):25-6
13279157
Am J Med. 1954 Aug;17(2):205-13
13180528
J Clin Invest. 1957 Aug;36(8):1193-201
13463081